the risk of stopping treatment may outweigh the theoretical risks to the fetus
Programs like Found offer these alternatives
So even if you qualify medically, your plan might still say no to Wegovy
Each month, this report provides insight into how the behaviors and attitudes of GLP-1 (e.g., Ozempic, Wegovy, etc.) users are transforming and how theyre impacting a range of industries from healthcare to retail, food service, fitness, apparel, and even travel
If you have any questions about our products, please feel free to contact us: Our consultants will be happy to inform you
Further tests guided by your history